Categories: HealthcareNews

Glenview Capital Issues Statement on CVS Health

NEW YORK, Oct. 1, 2024 /PRNewswire/ — We appreciate the skill and dedication of everyone at CVS Health and their daily efforts to make healthcare accessible, affordable and convenient for more than 120 million members and customers.  CVS Health is a systemically important healthcare institution whose consistency, quality and acumen has the potential to enhance wellness and health security for one in three Americans.  While the Company has tremendous assets across medical and pharmacy benefit management, specialty pharmacy, provider services and drug retail, the Company is operating well below its potential and has fallen short in its investment and actuarial approach in recent years, creating economic losses and volatility that pressures its people, its customers and its shareholders. 

Glenview and CVS Leadership are engaged in good faith and constructive conversations through which Glenview is offering suggestions to enhance the governance, culture, efficiency, sustainability and growth of CVS Health.  This dialogue is ongoing but is private and should remain so.  Press reports have represented that Glenview is pushing for a break-up of CVS Health – this is false.  Our goals are those shared by all stakeholders – to work together to strengthen CVS’s culture and operating performance to enhance value for customers, associates and shareholders alike. 

Together we build.

About Glenview Capital
In its 24th year of operations, Glenview Capital is a long-term investment partnership focused on fundamental investing.

CONTACT: Emma Tomas, etomas@hstrategies.com

View original content:https://www.prnewswire.com/news-releases/glenview-capital-issues-statement-on-cvs-health-302264708.html

SOURCE Glenview Capital

Staff

Recent Posts

Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative

Project AED365 Aims to Empower Communities, Youth Organizations, First Responders, and more by Providing Lifesaving Automated…

1 hour ago

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages…

1 hour ago

Blazesoft Spreads Holiday Cheer with $250,000 Donation to Mackenzie Health Foundation

This heartfelt donation demonstrates Blazesoft's commitment to corporate social responsibility with a generous gift to…

1 hour ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

GOLETA, Calif.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products…

4 hours ago

Bemax Inc. Announces Second Quarter Financial Results

- Revenue grew to $1,078,090, an increase of over $1million year-over-yearDallas, Georgia--(Newsfile Corp. - December…

4 hours ago

U.S. EHR Giants Drive Global Healthcare Digital Transformation Across 39 Countries, 2025 Black Book Reports

Epic, Oracle Health, MEDITECH and Altera Digital Health are redefining healthcare IT worldwide, as highlighted…

4 hours ago